Accendra Health, Inc.ACHNYSE
Loading
EV/EBITDA Over TimeContracting
Percentile Rank29
3Y CAGR-7.5%
5Y CAGR+1.2%
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

3Y CAGR
-7.5%/yr
Annual compound
5Y CAGR
+1.2%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20258.96-85.2%
202460.39+551.1%
20239.28-18.2%
202211.34+10.5%
202110.26+21.3%
20208.46-19.2%
201910.47+245.3%
2018-7.20-178.2%
20179.21+1.6%
20169.06-